M. Frazier

C. Amos, X. Gu, M. Frazier, 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Mammalian pancreatic preproglucagon contains three glucagon-related peptides.

A. Kumar, M. Frazier, G. Saunders, 1983, Proceedings of the National Academy of Sciences of the United States of America.

ARHI is the center of allelic deletion on chromosome 1p31 in ovarian and breast cancers

J. Gray, R. Bast, K. Hunt, 2000, International journal of cancer.

Few point mutations in elongation factor‐1γ gene in gastrointestinal carcinoma

M. Frazier, Yeul-Hong Kim, N. Inamdar, 1998 .

Restriction fragment length polymorphism of the human insulin gene region among type II diabetic Mexican-Americans and Tunisians.

R. Ferrell, M. Frazier, R. Arem, 1986, Research communications in chemical pathology and pharmacology.

Corrigendum: A genetic screen identies an LKB1–MARK signalling axis controlling the Hippo–YAP pathway

F. Camargo, Kwok-Kin Wong, M. Frazier, 2014, Nature Cell Biology.

Pancreatic adenocarcinoma cell line, MDAPanc-28, with features of both acinar and ductal cells

Douglas B. Evans, M. Frazier, J. Abbruzzese, 1996, International journal of pancreatology : official journal of the International Association of Pancreatology.

Distress in the cancer patient and its association with genetic testing and counseling for hereditary non-polyposis colon cancer

C. Amos, S. Marani, S. Vernon, 1999 .

Detection of mutated c-Ki-ras in the bile of patients with pancreatic cancer.

S. Leach, T. King, M. Frazier, 1997, Anticancer research.

Microsatellite instability in saliva from patients with hereditary non-polyposis colon cancer and siblings carrying germline mismatch repair gene mutations.

M. Frazier, L. Ramagli, M. Siciliano, 2011, Annals of clinical and laboratory science.

Gene Expression in Pancreatic Adenocarcinoma

M. Frazier, 1999, Annals of the New York Academy of Sciences.

Cis-acting elements required for expression of the nonspecific cross-reacting antigen gene in colorectal carcinoma.

M. Frazier, D. Jones, M. Manire, 1997, Gastroenterology.

Overexpression of Cyclooxygenase 2 in Hamartomatous Polyps of Peutz-Jeghers Syndrome

C. Amos, M. Frazier, M. Howett, 2003, American Journal of Gastroenterology.

SCF-KIT signaling induces endothelin-3 synthesis and secretion: Thereby activates and regulates endothelin-B-receptor for generating temporally- and spatially-precise nitric oxide to modulate SCF- and or KIT-expressing cell functions

S. Tripp, L. Ramdas, R. Benjamin, 2017, PloS one.

Carbonic Anhydrase II Gene Expression in Mouse Pancreatic Duct Cells

M. Frazier, S. Githens, J. A. Schexnayder, 1992, Pancreas.

Mouse pancreatic acinar/ductlar tissue gives rise to epithelial cultures that are morphologically, biochemically, and functionally indistinguishable from interlobular duct cell cultures

M. Frazier, G. Denning, S. Githens, 1994, In Vitro Cellular & Developmental Biology - Animal.

Insulin gene expression during development of the fetal bovine pancreas.

M. Frazier, G. Saunders, R. Montagna, 1981, Biochemistry.

Association between Aurora‐A kinase polymorphisms and age of onset of hereditary nonpolyposis colorectal cancer in a Caucasian population

S. Sen, C. Amos, M. Frazier, 2007, Molecular carcinogenesis.

Family History of Cancer in Patients with Colorectal Cancer Association of the CpG Island Methylator Phenotype with Updated Version

C. Amos, J. Issa, A. Rashid, 2003 .

Fine-mapping of the 5p15.33, 6p22.1-p21.31, and 15q25.1 Regions Identifies Functional and Histology-Specific Lung Cancer Susceptibility Loci in African-Americans

L. Bierut, M. Spitz, Xifeng Wu, 2012, Cancer Epidemiology, Biomarkers & Prevention.

Carbonic Anhydrase II Gene Expression in Cell Lines from Human Pancreatic Adenocarcinoma

D. Hewett‐Emmett, T. Ota, M. Frazier, 1990, Pancreas.

Expression of acinar and ductal products in capan‐1 cells growing in synthetic serum and serum‐free media

M. Frazier, R. de Llorens, C. M. Cuchillo, 1994, Cancer.

Potato Carboxypeptidase Inhibitor, a T-knot Protein, Is an Epidermal Growth Factor Antagonist That Inhibits Tumor Cell Growth*

E. Querol, F. Avilés, M. Frazier, 1998, The Journal of Biological Chemistry.

DEAR1 Is a Dominant Regulator of Acinar Morphogenesis and an Independent Predictor of Local Recurrence-Free Survival in Early-Onset Breast Cancer

K. Hunt, S. Sen, T. Buchholz, 2009, PLoS medicine.

Fine mapping of a genetic locus for Peutz-Jeghers syndrome on chromosome 19p.

C. Amos, M. Seldin, M. Frazier, 1997, Cancer research.

Investigational strategies for detection and intervention in early-stage pancreatic cancer

I. Zagon, S. Hubchak, M. Korc, 1994, International journal of pancreatology : official journal of the International Association of Pancreatology.

Methyl‐CpG‐binding domain 2

M. Spitz, Xifeng Wu, H. Grossman, 2004, Cancer.

ACase – Control Study of a Sex-Speci fi c Association between a 15 q 25 Variant and Lung Cancer Risk

M. Spitz, Xifeng Wu, C. Amos, 2011 .

Definitive Characterization of CA 19-9 in Resectable Pancreatic Cancer Using a Reference Set of Serum and Plasma Specimens

Sudhir Srivastava, Michael A. Hollingsworth, Randall E. Brand, 2015, PloS one.

p53 Polymorphism and Age of Onset of Hereditary Nonpolyposis Colorectal Cancer in a Caucasian Population

C. Amos, X. Gu, M. Frazier, 2004, Clinical Cancer Research.

Distribution of Cholecystokinin-B Receptor Genotype Between Patients With Pancreatic Cancer and Controls and Its Impact on Survival

R. Brand, M. Frazier, G. Matters, 2015, Pancreas.

Ectopic expression of mucins in colorectal cancer metastasis.

D. Ota, T. Irimura, M. Frazier, 1991, Seminars in cancer biology.

Putative tumor suppressor gene SEL1L was downregulated by aberrantly upregulated hsa‐mir‐155 in human pancreatic ductal adenocarcinoma

S. Sen, C. Amos, M. Frazier, 2014, Molecular carcinogenesis.

A Missense Mutation in KIT Kinase Domain 1 Correlates with Imatinib Resistance in Gastrointestinal Stromal Tumors

Wei Zhang, K. Hunt, G. Fuller, 2004, Cancer Research.

A Migration Signature and Plasma Biomarker Panel for Pancreatic Adenocarcinoma

S. Sen, M. Frazier, W. Grizzle, 2010, Cancer Prevention Research.

Aurora-A and p16 Polymorphisms Contribute to an Earlier Age at Diagnosis of Pancreatic Cancer in Caucasians

Douglas B. Evans, S. Sen, C. Amos, 2007, Clinical Cancer Research.

Evolution of Glucagon Genes 1

Wen-Hsiung Li, C. Luo, M. Frazier, 1998 .

Evolution of glucagon genes.

C. Luo, W. Li, M. Frazier, 1984, Molecular biology and evolution.

DNA repair: a double-edged sword.

B. Levin, M. Frazier, Q. Wei, 2000, Journal of the National Cancer Institute.

MicroRNAs in Plasma of Pancreatic Ductal Adenocarcinoma Patients as Novel Blood-Based Biomarkers of Disease

Ann M. Killary, Subrata Sen, S. Sen, 2009, Cancer Prevention Research.

Mutations in Non-MMR Genes Modifying or Mimicking Lynch Syndrome Phenotype

M. Frazier, Jinyun Chen, Chongjuan Wei, 2013 .

DNMT3b Polymorphism and Hereditary Nonpolyposis Colorectal Cancer Age of Onset

Q. Wei, C. Amos, X. Gu, 2006, Cancer Epidemiology Biomarkers & Prevention.

Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: growth inhibition by nonsteroidal anti-inflammatory drugs.

F. Sinicrope, M. Frazier, M. Lemoine, 1999, Cancer research.

CXCL1 mediates obesity-associated adipose stromal cell trafficking and function in the tumour microenvironment

P. Troncoso, C. Logothetis, M. Frazier, 2016, Nature Communications.

Structure and evolution of somatostatin genes.

C. Luo, W. Li, M. Frazier, 1988, Molecular endocrinology.

Expression of Elongation Factor‐1 Gamma‐Related Sequence in Human Pancreatic Cancer

M. Frazier, Dennie V. Jones, D. Byrd, 1992, Pancreas.

Expression of an elongation factor 1 gamma-related sequence in adenocarcinomas of the colon.

M. Frazier, D. Jones, K. Chi, 1992, Gastroenterology.

Hypomethylation andADA gene expression in mouse CAK cells

R. Stallings, M. Frazier, M. Al-Ubaidi, 1989, Somatic cell and molecular genetics.

Fine-mapping of the 5 p 15 . 33 , 6 p 22 . 1p 21 . 31 , and 15 q 25 . 1 Regions Identi fi es Functional and Histology-Speci fi c Lung Cancer Susceptibility Loci in African-Americans

L. Bierut, M. Spitz, Xifeng Wu, 2013 .

Association study of nicotinic acetylcholine receptor genes identifies a novel lung cancer susceptibility locus near CHRNA1 in African-Americans

M. Spitz, Xifeng Wu, C. Amos, 2012, Oncotarget.

A Case–Control Study of a Sex-Specific Association between a 15q25 Variant and Lung Cancer Risk

M. Spitz, Xifeng Wu, C. Amos, 2011, Cancer Epidemiology, Biomarkers & Prevention.

A genetic screen identifies an LKB1–MARK signalling axis controlling the Hippo–YAP pathway

Kwok-Kin Wong, F. Camargo, Kwok-Kin Wong, 2013, Nature Cell Biology.

Susceptibility Locus for Lung Cancer at 15q25.1 Is Not Associated With Risk of Pancreatic Cancer

Xifeng Wu, S. Sen, C. Amos, 2011, Pancreas.

Association of the CpG island methylator phenotype with family history of cancer in patients with colorectal cancer.

C. Amos, J. Issa, A. Rashid, 2003, Cancer research.

Cyclin D1b represses breast cancer cell growth by antagonizing the action of cyclin D1a on estrogen receptor alpha-mediated transcription.

S. Sen, M. Frazier, Jing Zhu, 2009, International journal of oncology.

Chemopreventive efficacy of rapamycin on Peutz-Jeghers syndrome in a mouse model.

C. Amos, Nianxiang Zhang, M. Frazier, 2009, Cancer letters.

Suppression of Peutz-Jeghers Polyposis by Targeting Mammalian Target of Rapamycin Signaling

C. Amos, Nianxiang Zhang, A. Rashid, 2008, Clinical Cancer Research.

A pilot study comparing protein expression in different segments of the normal colon and rectum and in normal colon versus adenoma in patients with Lynch syndrome

M. Frazier, Jinyun Chen, Chongjuan Wei, 2013, Journal of Cancer Research and Clinical Oncology.

Mutation of Lkb1 and p53 genes exert a cooperative effect on tumorigenesis.

C. Amos, A. Rashid, J. Deng, 2005, Cancer research.

Correlation of Staining for LKB1 and COX-2 in Hamartomatous Polyps and Carcinomas from Patients with Peutz–Jeghers Syndrome

C. Amos, M. Sabripour, A. Rashid, 2003, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Reverse-Phase Protein Array Analysis to Identify Biomarker Proteins in Human Pancreatic Cancer

Nianxiang Zhang, M. Frazier, Chongjuan Wei, 2013, Digestive Diseases and Sciences.

Estimating mutant microsatellite allele frequencies in somatic cells by small-pool PCR.

M. Frazier, L. Ramagli, M. Siciliano, 2004, Genomics.

Microsatellite instability in the insulin–like growth factor II receptor gene in gastrointestinal tumours

B. Leggett, S. Powell, Suna Wang, 1996, Nature Genetics.

Cancer Patients Circulation of Progenitor Cells in Obese and Lean Colorectal

M. Frazier, Jinyun Chen, M. Kolonin, 2011 .

Human cell line from an adenocarcinoma of the ampulla of vater

Douglas B. Evans, B. Levin, D. Byrd, 1992, In Vitro Cellular & Developmental Biology - Animal.

Cancer spectrum in DNA mismatch repair gene mutation carriers: results from a hospital based Lynch syndrome registry

C. Amos, M. Frazier, Jinyun Chen, 2012, Familial Cancer.

Genotype–phenotype correlations in Peutz-Jeghers syndrome

C. Amos, M. Sabripour, M. Seldin, 2004, Journal of Medical Genetics.

Missense mutations in hMLH1 and hMSH2 are associated with exonic splicing enhancers.

C. Amos, I. Gorlov, O. Gorlova, 2003, American journal of human genetics.

Circulating microRNAs in Pancreatic Juice as Candidate Biomarkers of Pancreatic Cancer

S. Sen, M. Wallace, M. Raimondo, 2014, Journal of Cancer.

Bleomycin clinical pharmacology by radioimmunoassay

R. Benjamin, M. Frazier, J. Strong, 2004, Cancer Chemotherapy and Pharmacology.

A mutation-created novel intra-exonic pre-mRNA splice site causes constitutive activation of KIT in human gastrointestinal stromal tumors

G. Fuller, M. Sabripour, M. Frazier, 2005, Oncogene.

For Peer Review Genetic variants in the vitamin D pathway and breast cancer disease-free survival

K. Do, A. Sahin, M. Frazier, 2012 .

Interplay between polymorphisms and methylation in the H19/IGF2 gene region may contribute to obesity in Mexican-American children

I. Gorlov, O. Gorlova, M. Frazier, 2013, Journal of Developmental Origins of Health and Disease.

Corrigendum: The insulin–like growth factor II receptor gene is a target of microsatellite instability in human gastrointestinal tumours

B. Leggett, S. Powell, Suna Wang, 1996, Nature Genetics.

DNA pooling in mutation detection with reference to sequence analysis.

C I Amos, C. Amos, M. Frazier, 2000, American journal of human genetics.

Age-associated risk of cancer among individuals with N-acetyltransferase 2 (NAT2) mutations and mutations in DNA mismatch repair genes.

C. Amos, X. Gu, M. Frazier, 2001, Cancer research.

Mismatch Repair Genes ) Mutations and Mutations in DNA NAT 2-Acetyltransferase 2 ( N Age-associated Risk of Cancer among Individuals with Updated Version

C. Amos, X. Gu, M. Frazier, 2001 .

Advances in Brief Age-associated Risk of Cancer among Individuals with N-Acetyltransferase 2 ( NAT 2 ) Mutations and Mutations in DNA Mismatch Repair Genes 1

C. Amos, X. Gu, M. Frazier, 2001 .

Genetic variants in the vitamin D pathway and breast cancer disease-free survival.

K. Do, C. Amos, A. Sahin, 2013, Carcinogenesis.

Evolution from heterozygous to homozygous KIT mutation in gastrointestinal stromal tumor correlates with the mechanism of mitotic nondisjunction and significant tumor progression

K. Hunt, Wei Zhang, Haesun Choi, 2008, Modern Pathology.

IGF1 gene polymorphism and risk for hereditary nonpolyposis colorectal cancer.

C. Amos, X. Gu, M. Frazier, 2006, Journal of the National Cancer Institute.

Interactions between cigarette smoking and selected polymorphisms in xenobiotic metabolizing enzymes in risk for colorectal cancer: A case‐only analysis

C. Amos, M. Frazier, C. Eng, 2010, Molecular carcinogenesis.

Exploiting antitumor immunity to overcome relapse and improve remission duration

A. Lazar, Haesun Choi, P. Lin, 2011, Cancer Immunology, Immunotherapy.

R. Scott, C. Amos, I. Gorlov, 2013, Carcinogenesis.

Single Nucleotide Polymorphisms of RecQ 1 , RAD 54 L and ATM Genes Are Associated With Reduced Survival of Pancreatic Cancer

K. Hess, Douglas B. Evans, Donghui Li, 2008 .

Single nucleotide polymorphisms of RecQ1, RAD54L, and ATM genes are associated with reduced survival of pancreatic cancer.

K. Hess, Douglas B. Evans, Donghui Li, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II trial of imatinib mesylate in patients with metastatic melanoma

M. Ross, C. Ng, J. Gershenwald, 2008, British Journal of Cancer.

Phase II trial of imatinib mesylate (STI-571) in metastatic melanoma (MM).

M. Frazier, A. H. Diwan, V. Prieto, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Microsatellite instability in the peripheral blood leukocytes of HNPCC patients

M. Frazier, L. Ramagli, M. Siciliano, 2010, Human mutation.

Identification of genetic variants predictive of early onset pancreatic cancer through a population science analysis of functional genomic datasets

Xifeng Wu, S. Sen, W. Chen, 2016, Oncotarget.

Evidence for Linkage of Postchallenge Insulin Levels With Intestinal Fatty Acid-Binding Protein (FABP2) in Mexican-Americans

P. O’Connell, B. Mitchell, M. Stern, 1995, Diabetes.

Polymorphisms of p16, p27, p73, and MDM2 Modulate Response and Survival of Pancreatic Cancer Patients Treated with Preoperative Chemoradiation

Douglas B. Evans, S. Sen, C. Amos, 2009, Annals of Surgical Oncology.

Cyclin D1 polymorphism and risk for squamous cell carcinoma of the head and neck: a case-control study.

M. Spitz, E. Sturgis, S. Strom, 2001, Carcinogenesis.

Genetic Variants of p21 and p27 and Pancreatic Cancer Risk in Non-Hispanic Whites: A Case-Control Study

S. Sen, Q. Wei, C. Amos, 2010, Pancreas.

Polymorphisms of p21 and p27 jointly contribute to an earlier age at diagnosis of pancreatic cancer.

Douglas B. Evans, S. Sen, C. Amos, 2008, Cancer letters.

Next generation sequencing of pancreatic cyst fluid microRNAs from low grade-benign and high grade-invasive lesions.

Han Liang, Pamela L. Paris, Vy Ngo, 2015, Cancer letters.

Cyclin D1 polymorphism and increased risk of colorectal cancer at young age.

C. Amos, B. Levin, M. Frazier, 2001, Journal of the National Cancer Institute.

Genetic variants in the cell cycle control pathways contribute to early onset colorectal cancer in Lynch syndrome

C. Amos, Qing Zhang, N. Lindor, 2009, Cancer Causes & Control.

Regulation of sialomucin production in colon carcinoma cells.

T. Irimura, M. Frazier, S. Nakamori, 1993, The Journal of biological chemistry.

A Plasma Biomarker Panel to Identify Surgically Resectable Early-Stage Pancreatic Cancer

Tracey L Marsh, S. Sen, R. Brand, 2017, Journal of the National Cancer Institute.

High frequency loss of heterozygosity in von Hippel-Lindau (VHL)-associated and sporadic pancreatic islet cell tumors: evidence for a stepwise mechanism for malignant conversion in VHL tumorigenesis.

S. Curley, L. Strong, M. Frazier, 2002, Cancer research.

Cancer spectrum in DNA mismatch repair gene mutation carriers: results from a hospital based Lynch syndrome registry

C. Amos, M. Frazier, Jinyun Chen, 2012, Familial Cancer.

Genetic Variation in Genes for the Xenobiotic-Metabolizing Enzymes CYP1A1, EPHX1, GSTM1, GSTT1, and GSTP1 and Susceptibility to Colorectal Cancer in Lynch Syndrome

C. Amos, R. Broaddus, M. Frazier, 2008, Cancer Epidemiology Biomarkers & Prevention.

Risk Factors for Colorectal Cancer Susceptibility

C. Amos, M. Frazier, C. Bosken, 2005 .

Activation of Liver FGF21 in hepatocarcinogenesis and during hepatic stress

Randy L. Johnson, Yanqing Huang, M. Frazier, 2013, BMC Gastroenterology.

Circulation of Progenitor Cells in Obese and Lean Colorectal Cancer Patients

M. Frazier, Jinyun Chen, M. Kolonin, 2011, Cancer Epidemiology, Biomarkers & Prevention.

Reduction in hMSH2 mRNA Levels by Premature Translation Termination (Implications for Mutation Screening in Hereditary Nonpolyposis Colorectal Cancer)

M. Frazier, P. Lynch, Xuede Lin, 2004, Digestive Diseases and Sciences.

Genetic and nongenetic covariates of pain severity in patients with adenocarcinoma of the pancreas: assessing the influence of cytokine genes.

E. Bruera, M. Spitz, Douglas B. Evans, 2009, Journal of pain and symptom management.

Effects of cyclin D1 polymorphism on age of onset of hereditary nonpolyposis colorectal cancer.

C. Amos, B. Levin, M. Frazier, 2000, Cancer research.

Influence of Methylenetetrahydrofolate Reductase Gene Polymorphisms C677T and A1298C on Age-Associated Risk for Colorectal Cancer in a Caucasian Lynch Syndrome Population

C. Amos, R. Broaddus, M. Frazier, 2007, Cancer Epidemiology Biomarkers & Prevention.

Imatinib resistance in gastrointestinal stromal tumors

M. Sabripour, Haesun Choi, B. Feig, 2005, Current oncology reports.

Mutations of HNRNPA0 and WIF1 predispose members of a large family to multiple cancers

C. Boland, C. Amos, W. Chen, 2015, Familial Cancer.

Surgical decision-making affected by clinical and genetic screening of a novel kindred with von Hippel-Lindau disease and pancreatic islet cell tumors.

S. Curley, M. Frazier, A. Killary, 1998, Annals of surgery.

Predominant expression of mRNA coding for nonspecific cross-reacting antigen in colorectal carcinomas.

M. Frazier, J. Jessup, K. Chi, 1991, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

ATM Polymorphism and hereditary nonpolyposis colorectal cancer (HNPCC) ageof onset (United States)

C. Amos, X. Gu, M. Frazier, 2005, Cancer Causes & Control.

Mutation of the hMSH2 gene in two families with hereditary nonpolyposis colorectal cancer

J. Ajani, B. Levin, M. Frazier, 1996, Human mutation.

Cloning and nucleotide sequence analysis of complementary deoxyribonucleic acid for bovine preproinsulin.

M. Frazier, J. W. White, M. Younes, 1987, Molecular endocrinology.

Current applications of genetic technology in predisposition testing and microsatellite instability assays.

C. Amos, M. Frazier, P. Lynch, 2000, Journal of Clinical Oncology.

MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines.

G. Mills, W. Yung, L. Ellis, 1997, Cancer research.

Advances in Brief High Frequency Loss of Heterozygosity in von Hippel-Lindau ( VHL )-associated and Sporadic Pancreatic Islet Cell Tumors : Evidence for a Stepwise Mechanism for Malignant Conversion in VHL Tumorigenesis 1

S. Curley, L. Strong, M. Frazier, 2002 .

Erratum to: Mutations of HNRNPA0 and WIF1 predispose members of a large family to multiple cancers

D. Chaussabel, C. Amos, W. Chen, 2015, Familial Cancer.

A Migration Signature and Plasma Biomarker Panel for Pancreatic Adenocarcinoma

S. Sen, M. Frazier, W. Grizzle, 2010, Cancer Prevention Research.

Suppression of Peutz-Jeghers Polyposis by Targeting Mammalian Target of Rapamycin Signaling

C. Amos, Nianxiang Zhang, A. Rashid, 2008, Clinical Cancer Research.

MicroRNAs in Plasma of Pancreatic Ductal Adenocarcinoma Patients as Novel Blood-Based Biomarkers of Disease

S. Sen, Donghui Li, M. Frazier, 2009, Cancer Prevention Research.

DEAR1 is a chromosome 1p35 tumor suppressor and master regulator of TGF-β-driven epithelial-mesenchymal transition.

Yu Cao, S. Sen, I. Wistuba, 2013, Cancer discovery.

Phase II trial of imatinib mesylate in patients with metastatic melanoma

M. Ross, C. Ng, J. Gershenwald, 2008, British Journal of Cancer.

Localization of an abundant myeloid mRNA to individual leukocytes in mixed cell populations.

W. Mars, M. Frazier, S. Stass, 1987, Leukemia.

Attitudes towards colorectal cancer screening in Lynch syndrome families: how do they change from pre-test genetic counseling to 6 and 12-months post-disclosure?

Salma K. Marani, C. Amos, S. Vernon, 2011, Hereditary Cancer in Clinical Practice.